Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the prevalence at 3.5 months of age of dumping syndrome in children operated at birth for oesophageal atresia type III et IV.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Lille
NCT06731855 · Gastroschisis, Congenital Diaphragmatic Hernia, and more
NCT05057819 · Dumping Syndrome, Hypoglycemia, Reactive
NCT01923649 · Dumping Syndrome
NCT02971631 · Gastric Cancer, Dumping Syndrome
NCT03200782 · Postprandial Hypoglycemia, Bariatric Surgery, and more
Hôpital Pellegrin - Hôpital d'Enfants,
Bordeaux
CHU Grenoble
Grenoble
Hôpital Jeanne de Flandre CHRU
Lille
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions